You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease Type II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

Not yet recruiting
  • Pompe Disease
  • +7 more
  • Multi-ingredient supplement (PDT-MIS)
  • Placebo (PLA)
  • (no location specified)
Nov 8, 2023

Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

Not yet recruiting
  • Pompe Disease
  • McArdle Disease
  • Siemens Magnetom 7T Plus
  • Vienna, Austria
    Medical University of Vienna
Jul 5, 2023

Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

Completed
Has Results
  • Pompe Disease
  • +2 more
  • alglucosidase alfa
  • Gainesville, Florida
  • +2 more
Jul 29, 2022

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

Recruiting
  • Glycogen Storage Disease
  • +2 more
  • No intervention
  • Copenhagen, Copenhange, Denmark
    Neuromuscular Research Unit, 8077
Oct 26, 2022

Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

Recruiting
  • Glycogen Storage Disease Type II
  • Pompe Disease (Late-onset)
  • Inspiratory Muscle Training (IMT)
  • Inspiratory Muscle Training (IMT) + Air Stacking
  • Milan, Italy
    IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
Jul 11, 2023

Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

Recruiting
  • Glycogen Storage Disease Type II Infantile Onset
  • Gainesville, Florida
    University of Florida Clinical Research Center
Jan 18, 2023

Pompe Disease (Late-onset) Trial (No Intervention)

Not yet recruiting
  • Pompe Disease (Late-onset)
  • No Intervention
  • (no location specified)
Nov 21, 2023

Natural History of Pompe Disease

Recruiting
  • Glycogen Storage Disease Type II, Adult
    • Garches, Hauts-de-Seine, France
      Hôpital Raymond Poincaré
    Apr 20, 2022

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
    • There is no intervention
    • San Francisco, California
      University of California San Francisco
    Nov 9, 2022

    Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

    Recruiting
    • Glycogen Storage Disease Type II
    • Alglucosidase alfa GZ419829
    • Leuven, Belgium
    • +8 more
    Jan 17, 2023

    Pompe Disease Trial in New York, Fairfax (biological, drug, other)

    Not yet recruiting
    • Pompe Disease
    • Cipaglucosidase alfa
    • +3 more
    • New York, New York
    • +1 more
    Nov 2, 2023

    Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States

    Terminated
    Has Results
    • Pompe Disease
    • +2 more
    • Myozyme® (alglucosidase alfa)
    • Louisville, Kentucky
    • +4 more
    Mar 24, 2022

    ERT in Pompe Disease: Elucidation of Molecular Structures

    Not yet recruiting
    • Pompe-Disease
      • Rüsselsheim, Hessen, Germany
        Centre for Analytical Biochemistry
      Jan 30, 2023

      Glycogen Storage Disease Type II Trial in France (Avalglucosidase alfa (GZ402666))

      Recruiting
      • Glycogen Storage Disease Type II
      • Avalglucosidase alfa (GZ402666)
      • Brest, France
      • +9 more
      Jul 22, 2022

      Cognitive and Neurological Pathologies in Pompe Disease

      Recruiting
      • Pompe Disease
        • Durham, North Carolina
          Duke University Medical Center
        Jun 30, 2022

        Pompe Disease (Late-onset) Trial in Durham (Clenbuterol, Placebos)

        Withdrawn
        • Pompe Disease (Late-onset)
        • Durham, North Carolina
          Duke University Medical Center
        Aug 15, 2022

        Avalglucosidase Alfa Pregnancy Study

        Recruiting
        • Pompe Disease
        • Pregnancy
        • avalglucosidase alfa-NGPT (GZ402666) IV
        • avalglucosidase alfa-NGPT (GZ402666)
        • Bridgewater, New Jersey
          Investigational site worldwide
        Feb 15, 2023

        Pompe's Disease Trial in China (ALGLUCOSIDASE ALFA)

        Recruiting
        • Pompe's Disease
        • ALGLUCOSIDASE ALFA
        • China, China
          Investigational Site
        Oct 26, 2022

        Glycogen Storage Disease Type II Trial in Worldwide (avalglucosidase alfa)

        Recruiting
        • Glycogen Storage Disease Type II
        • avalglucosidase alfa
        • Leuven, Belgium
        • +7 more
        Jul 13, 2022

        Late-onset Pompe Disease Trial in Gainesville, London (Respiratory muscle strength measurements by different techniques.)

        Terminated
        Has Results
        • Late-onset Pompe Disease
        • Respiratory muscle strength measurements by different techniques.
        • Gainesville, Florida
        • +1 more
        Apr 11, 2022

        Pompe Disease, Pompe Disease (Late-onset), Pompe's Disease Juvenile Onset Trial in Erlangen (Multispectral Optoacoustic

        Recruiting
        • Pompe Disease
        • +3 more
        • Multispectral Optoacoustic Tomography
        • Erlangen, Bavaria, Germany
          University Hospital Erlangen
        Jun 2, 2022

        Glycogen Storage Disease Type II Pompe Disease Trial in Worldwide (GZ402666)

        Completed
        • Glycogen Storage Disease Type II Pompe Disease
        • Phoenix, Arizona
        • +16 more
        Dec 14, 2022

        Higher Dose of Alglucosidase Alpha for Pompe Disease

        Not yet recruiting
        • Glycogen Storage Disease Type II
        • Alglucosidase Alfa
        • (no location specified)
        Aug 17, 2021

        Late-Onset Pompe Disease, Lysosomal Disease Trial in Durham (IMT therapy using the Pr02 mobile device)

        Recruiting
        • Late-Onset Pompe Disease
        • Lysosomal Disease
        • IMT therapy using the Pr02 mobile device
        • Durham, North Carolina
          Duke University Medical Center
        Jul 21, 2022

        Patients With "Late-Onset" Pompe Disease

        Active, not recruiting
        • Pompe Disease
        • +2 more
        • Observational
        • Durham, North Carolina
          Duke University
        Oct 7, 2022